Dynamix Corp Files S-1/A Amendment

TL;DR

Dynamix Corp just filed an S-1/A amendment, looks like they're still prepping for an IPO.

AI Summary

Dynamix Corporation filed an S-1/A amendment on October 25, 2024, for its registration statement (No. 333-280719). The filing, originating from Grand Cayman, details its principal executive offices in Houston, Texas, with Andrea Bernatova serving as CEO. The company is incorporated in the Cayman Islands and operates within the 'BLANK CHECKS' SIC code.

Why It Matters

This S-1/A filing indicates Dynamix Corp is moving forward with its public offering process, which could lead to new investment opportunities and increased market activity for the company.

Risk Assessment

Risk Level: medium — S-1/A filings are part of the IPO process, which inherently carries risks related to market reception and company execution.

Key Numbers

• 333-280719 — SEC Registration Number (Identifies the specific registration statement being amended.)

Key Players & Entities

• Dynamix Corporation (company) — Registrant
• October 25, 2024 (date) — Filing date
• 333-280719 (registration_number) — SEC Registration Number
• Andrea Bernatova (person) — Chief Executive Officer
• Grand Cayman (location) — Business Address Jurisdiction
• Houston, TX (location) — Principal Executive Offices

FAQ

Key Financial Figures

• $150,000,000 — 00a0;OCTOBER  25 , 2024 $150,000,000 Dynamix Corporation 15,000,000&#x00
• $10.00 — ies. Each unit has an offering price of $10.00 and consists of one Class A ordi
• $11.50 — s A ordinary share at a price of $11.50 per share, subject to adjustment as des
• $0.65 — ncluding the Company, to repurchase, at $0.65 per public warrant (exclusive of commis
• $0.20 — x00a0;    Includes $0.20 per unit sold in the offering, or $3,00
• $3,000,000 — $0.20 per unit sold in the offering, or $3,000,000 in the aggregate (or $3,450,000 if the
• $3,450,000 — ing, or $3,000,000 in the aggregate (or $3,450,000 if the overallotment option is exercise
• $0.40 — closing of this offering; also includes $0.40 per unit sold in the offering, or $6,00
• $6,000,000 — $0.40 per unit sold in the offering, or $6,000,000 in the aggregate (or $6,900,000 if the
• $6,900,000 — ing, or $6,000,000 in the aggregate (or $6,900,000 if the overallotment option is exercise
• $150,375,000 — warrants described in this prospectus, $150,375,000, or $172,931,250 if the underwriters&#x
• $172,931,250 — ed in this prospectus, $150,375,000, or $172,931,250 if the underwriters’ overallotme
• $10.025 — rallotment option is exercised in full ($10.025 per unit in either case), will be place
• $25,000 — sed) for an aggregate purchase price of $25,000, or approximately $0.004 per share. The
• $0.004 — hase price of $25,000, or approximately $0.004 per share. The Class B ordinary

Filing Documents

• ea0208994-06.htm (S-1/A) — 4943KB
• ea020899406ex3-3_dynamix.htm (EX-3.3) — 289KB
• ea020899406ex5-2_dynamix.htm (EX-5.2) — 55KB
• ea020899406ex23-1_dynamix.htm (EX-23.1) — 2KB
• ex5-2_001.jpg (GRAPHIC) — 24KB
• ex5-2_002.jpg (GRAPHIC) — 12KB
• 0001213900-24-090840.txt ( ) — 5341KB

Dilution

Dilution   47 Summary Financial Data   49 Risks   50

Risk Factors

Risk Factors   52 Cautionary Note Regarding Forward-Looking Statements   100

Use of Proceeds

Use of Proceeds   102 Dividend Policy   105

Dilution

Dilution   106 Capitalization   108 Management’s Discussion and Analysis of Financial Condition and Results of Operations   109 Proposed Business   115 Effecting our Initial Business Combination   133 Management   155 Principal Shareholders   167 Certain Relationships and Related Party Transactions   170

Description of Securities

Description of Securities   173 Certain Income Tax Considerations   194

Underwriting

Underwriting   206 Legal Matters   216 Experts   216 Where You Can Find Additional Information   216 Index to Financial Statements   F-1 We are responsible for the information contained in this prospectus. We have not, and the underwriters have not, authorized anyone to provide you with information that is different from or inconsistent with that contained in this prospectus. We are not, and the underwriters are not, making an offer to sell securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this prospectus is accurate as of any date other than the date on the front of this prospectus . i Table of Contents Trademarks This prospectus contains references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus may appear without the ® or ™ symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies’ trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. ii Table of Contents Summary This

View Full Filing

View this S-1/A filing on SEC EDGAR